|
|
 |
|
|
<< Back
Research on Malignancies in the Context of HIV/AIDS (R21)
|
|
Description
|
Grant Amont: Unspecified.
The purpose of this funding opportunity announcement (FOA) is to advance the understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS). Through this FOA, the NCI and NIDCR seek to encourage research in areas such as the study of the etiologic factors, cofactors, pathogenesis, and consequences of HIV-associated malignancies in [the members of] diverse populations. Research on non-AIDS defining malignancies in the context of HIV infection is also encouraged. The incidence of non-AIDS-defining malignancies (e.g., anal, skin, and lung cancers as well as Hodgkin’s disease) appear to be increasing in the era of Highly Active Antiretroviral Treatment (HAART). This FOA extends to research efforts that will (i) provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection for the development and pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the HIV-infected population.
|
|
|
|
|
Funding Organization
|
US Department of Health and Human Services
Public Health Service
National Cancer Institute
National Institutes of Health
Office of Communications
National Institute of Dental and Craniofacial Research
|
|
|
|
|
|
|
|
|
|
Eligible Organizations
|
Colleges/Universities
Commercial Organizations
Community Based Organizations
Educational Organizations/Institutions
Federal Government Agencies
International Agencies
IRS 501 (c)(3) Organizations
Minority Owned Organizations
Nonprofit Organizations
Religious Organizations
State Agencies
Tribal Organizations
|
|
|
|
Award Amount Notes
|
Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. The R21 is not renewable.
|
|
|
|
|
Application Due Date
|
| 1/7/2010 -- Cycle III: 01/07/2010 |
|
|
|
|
|
Application Contact
|
Brett Hodgkins
Office of Grants Administration
National Cancer Institute
6120 Executive Boulevard
EPS Room 243, MSC 7150
Bethesda, MD 208927150
Phone: (301) 496-8657
Fax: (301) 496-8601
|
|
|
|
Technical Contact
|
Geraldina Dominguez, Ph.D.
Office AIDS Malignancy ProgramNational Cancer Institute, NIH
6120 Executive Boulevard
EPS Room 6114
Rockville, MD 20852
Phone: (301) 496-4995
Fax: (301) 480-4137
|
|
|
|
|
|
Subjects
|
Cancer
Persons with HIV/AIDS
Research Programs
|
|
|
|
|
|
|
|
Application Process
|
Prepare all applications using the SF424 (R&R) application forms and in accordance with the SF424 (R&R) Application Guide (MS Word or PDF).
To download the SF424 (R&R) Application Package and SF424 (R&R) Application Guide for completing the SF424 (R&R) forms for this FOA, link to http://www.grants.gov/Apply/ and follow the directions provided on that website. For further assistance, contact GrantsInfo: telephone (301) 435-0714, or e-mail GrantsInfo@nih.gov. The telecommunications number for the hearing impaired is TTY 301-451-0088. Applications must only be submitted electronically; paper applications will not be accepted.
The SF424 (R&R) Application Guide is critical to submitting a complete and accurate application to NIH. There are fields within the SF424 (R&R) application components that, although not marked as mandatory, are required by NIH (e.g., the “Credential” log-in field of the “Research & Related Senior/Key Person Profile” component must contain the PD/PI’s assigned eRA Commons User ID). Agency-specific instructions for such fields are clearly identified in the Application Guide. For additional information, see “Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications.”
See http://grants.nih.gov/grants/guide/pa-files/PA-07-454.html#SectionVIII for details on application submission. |
|
|
|
Notes
|
| This FOA will use the NIH exploratory/developmental (R21) grant mechanism and runs in parallel with a FOA of identical sceintific scope, PA-07-455, which solicits applications under the NIH Research Project R)1 grant mechanism. |
|
|
|
|
|
|
|
|
Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, news, funding opportunities, organizations, and conferences do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.
|
|
|
cdcnpin.org Fund Record #3943
|
|
<< Back
|
|
|
|
